EVENTS:   Best Equity Short Ideas Conference Call 12 - Zach Shannon/Corto Capital Advisors & Craig Huber/Huber Research Partners & Thomas Beevers /Forensic Alpha & Ed Steele/Iron Blue Financials & Bill Campbell/Paragon Intel - 12 Nov 25   Will AI Deflate the World? Macro Lessons from Three Industrial Revolutions and China - Manoj Pradhan/Talking Heads Macro - 13 Nov 25     ROADSHOWS: Forest Products Sector Equity and Commodity Research With Expertise in Distressed Debt - Kevin Mason /ERA Research   •   London   12 - 14 Nov 25       Buyside to Buyside Forum and Expert Calls across TMT, Consumer, Healthcare and Fintech - Andrew Peters /Revelare Partners   •   London   17 - 19 Nov 25       Fundamental US Healthcare Short Ideas - Dr Elliot Favus /Favus Institutional Research   •   London   17 - 19 Nov 25      

Fortnightly Publication Highlighting Latest Insights From IRF Providers

Company Research

ZoomInfo (ZI)

Technology

Corto Capital Advisors

The share price fell nearly 20% after the company reported worse-than-expected results and is now down over 50% since Zach Shannon recommended shorting ZI in Feb 24, having missed and guided down in each of the subsequent quarters. This week, the company finally cut its full year outlook, wrote off $33m in previously recognised revenue and announced the departure of its CFO. ZI now sees a full-year revenue decline (vs. previous guidance for growth) - something Zach has been flagging all year. In early July, he recommended reducing / covering short exposure on takeover speculation, with a recommendation to re-short into the print.

Edition: 192

- 09 August, 2024


ZoomInfo (ZI)

Technology

Abacus Research

A unique asset that provides a ‘must have’, high ROI data collection and automation tool for salespeople - ZI has been the first to reach scale and competition will struggle to catch up. The fact that the product sells itself is shown by ZI‘s >45% operating margin since 2018 along with 50%+ growth despite being in the early adoption stage. LTV/CAC of >10x. Abacus estimate revenue growth of 41% CAGR 2021-25 (vs. company guidance and consensus of 29% p.a.). TP $102 (55% upside).

Edition: 122

- 29 October, 2021